Absolute Antibody Launches VivopureX™ Recombinant Antibodies for In Vivo Research

Engineered antibodies available in bulk-discounted sizes improve research results in mouse models. REDCAR, UNITED KINGDOM (PRWEB) JANUARY 07, 2020 Absolute Antibody Ltd., an industry-leading provider of recombinant antibody products and services, today announced the launch of its VivopureX™ recombinant mouse antibodies for in vivo research in mouse models. The collection consists[…]

Read more

G-CON Manufacturing Announces the Unveiling of a New 25,000 Sq. ft. Facility for POD Manufacturing

New facility will enable G-CON to meet additional demand for prefabricated cleanroom solutions. COLLEGE STATION, TEXAS (PRWEB) JANUARY 07, 2020 G-CON Manufacturing, the leader in prefabricated, flexible cleanroom solutions, today unveiled another facility expansion, adding to the company’s 200,000 sq. ft. manufacturing site in College Station, TX. The new facility, opening[…]

Read more

Catalent Completes Purchase of Biologics Fill-Finish and Oral Solid Dose Facility in Anagni, Italy

SOMERSET, N.J. (PRWEB) JANUARY 07, 2020 Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer health products, today announced the completion of the purchase of Bristol-Myers Squibb’s biologics, sterile, and oral solid dose product manufacturing and packaging facility in Anagni,[…]

Read more

Vuja De Sciences Announces the Appointment of Two New Board Members

New members bring unparallel scientific and clinical expertise to anti-metastasis approaches in osteosarcoma and cancer in general, for both human and veterinary settings. HOBOKEN, N.J. (PRWEB) JANUARY 07, 2020 Vuja De Sciences (“Vuja De”), a biotechnology startup dedicated to developing cancer metastasis treatments that prevent cancer progression and recurrence, today announced[…]

Read more